Please use this identifier to cite or link to this item:
10.2478/prolas-2021-0025
| Title: | Immunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environment |
| Authors: | Hartmane, Ilona Ivdra, Iveta Mikažāns, Ingmārs Bondare-Ansberga, Vanda Department of Dermatology and Venereology |
| Keywords: | autoimmune skin disorder;biological therapy;state compensation;Baltic;3.2 Clinical medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database |
| Issue Date: | 1-Jun-2021 |
| Citation: | Hartmane , I , Ivdra , I , Mikažāns , I & Bondare-Ansberga , V 2021 , ' Immunopathogenic treatment options for psoriasis patients under a restrictive reimbursement environment ' , Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. , vol. 75 , no. 3 , pp. 158-166 . https://doi.org/10.2478/prolas-2021-0025 |
| Abstract: | This article is aimed to provide an overview of psoriasis clinical aspects, available treatment options for moderate-to-severe psoriasis in Baltics and summarises recommendations of authors for use of different biologicals in psoriasis patients under a limited reimbursement environment. |
| Description: | Publisher Copyright: © 2020 Ilona Hartmane et al., published by Sciendo. |
| DOI: | 10.2478/prolas-2021-0025 |
| ISSN: | 2255-890X |
| Appears in Collections: | Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| Immunopathogenic_treatment_options_for_psoriasis_patients.pdf | 583.42 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.